D. Western Therapeutics Sees FY Loss Y680.00M

Dow Jones

May 15, 2025

 D. Western Therapeutics Institute Inc. also released the following forecasts: 
GROUP Year Ending 
Dec 2025 
Revenue Y400.00 mln 
Operating Profit (Y670.00 mln) 
Pretax Profit (Y680.00 mln) 
Net Profit (Y680.00 mln) 
Per share 
Earnings (Y15.88) 
Figures in parentheses are losses. 
Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

 D. Western Therapeutics Institute Inc. (4576.TO) 
Japan 
1st Quarter Ended March 31 
GROUP 2025 2024 
Revenue Y96.00 mln Y104.00 mln 
Operating Profit (Y142.00 mln) (Y318.00 mln) 
Pretax Profit (Y149.00 mln) (Y320.00 mln) 
Net Profit (Y150.00 mln) (Y320.00 mln) 
Per share 
Earnings (Y3.41) (Y9.99) 
Figures in parentheses are losses. 
Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

May 15, 2025 02:42 ET (06:42 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2535642248"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535642248\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535642248?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 14:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535642248","market":"hk","top_or_hot":-1,"title":"D. Western Therapeutics Sees FY Loss Y680.00M","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. also released the following forecasts: </td></tr><tr><td>GROUP</td><td>Year Ending </td></tr><tr><td></td><td>Dec 2025 </td></tr><tr><td>Revenue</td><td>Y400.00 mln </td></tr><tr><td>Operating Profit</td><td>(Y670.00 mln) </td></tr><tr><td>Pretax Profit</td><td>(Y680.00 mln) </td></tr><tr><td>Net Profit</td><td>(Y680.00 mln) </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>(Y15.88) </td></tr><tr><td></td><td>Figures in parentheses are losses. </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>D. Western Therapeutics Institute Inc. (4576.TO) </td></tr><tr><td></td><td>Japan </td></tr><tr><td></td><td>1st Quarter Ended March 31 </td></tr><tr><td>GROUP</td><td>2025</td><td>2024 </td></tr><tr><td>Revenue</td><td>Y96.00 mln</td><td>Y104.00 mln </td></tr><tr><td>Operating Profit</td><td>(Y142.00 mln)</td><td>(Y318.00 mln) </td></tr><tr><td>Pretax Profit</td><td>(Y149.00 mln)</td><td>(Y320.00 mln) </td></tr><tr><td>Net Profit</td><td>(Y150.00 mln)</td><td>(Y320.00 mln) </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>(Y3.41)</td><td>(Y9.99) </td></tr><tr><td></td><td>Figures in parentheses are losses. </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2025 02:42 ET (06:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>D. Western Therapeutics Sees FY Loss Y680.00M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nD. Western Therapeutics Sees FY Loss Y680.00M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-15 14:42</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. also released the following forecasts: </td></tr><tr><td>GROUP</td><td>Year Ending </td></tr><tr><td></td><td>Dec 2025 </td></tr><tr><td>Revenue</td><td>Y400.00 mln </td></tr><tr><td>Operating Profit</td><td>(Y670.00 mln) </td></tr><tr><td>Pretax Profit</td><td>(Y680.00 mln) </td></tr><tr><td>Net Profit</td><td>(Y680.00 mln) </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>(Y15.88) </td></tr><tr><td></td><td>Figures in parentheses are losses. </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre><table><tbody><tr><td></td><td>D. Western Therapeutics Institute Inc. (4576.TO) </td></tr><tr><td></td><td>Japan </td></tr><tr><td></td><td>1st Quarter Ended March 31 </td></tr><tr><td>GROUP</td><td>2025</td><td>2024 </td></tr><tr><td>Revenue</td><td>Y96.00 mln</td><td>Y104.00 mln </td></tr><tr><td>Operating Profit</td><td>(Y142.00 mln)</td><td>(Y318.00 mln) </td></tr><tr><td>Pretax Profit</td><td>(Y149.00 mln)</td><td>(Y320.00 mln) </td></tr><tr><td>Net Profit</td><td>(Y150.00 mln)</td><td>(Y320.00 mln) </td></tr><tr><td>Per share </td><td></td></tr><tr><td>Earnings</td><td>(Y3.41)</td><td>(Y9.99) </td></tr><tr><td></td><td>Figures in parentheses are losses. </td></tr><tr><td></td><td>Results are based on Japanese accounting standards. </td></tr></tbody></table></pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2025 02:42 ET (06:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2535642248","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535642248","pubTimestamp":1747291320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"D. Western Therapeutics Institute Inc. also released the following forecasts: GROUPYear Ending Dec 2025 RevenueY400.00 mln Operating Profit Pretax Profit Net Profit Per share Earnings Figures in parentheses are losses. Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4168":"多种金属与采矿","BK4007":"制药","BK4139":"生物科技","LENZ":"Therapeutics","WRN":"西方铜金"},"translate_title":"D.Western Therapeutics预计财年亏损6.80亿日元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"WRN":1},"content_text":"D. Western Therapeutics Institute Inc. also released the following forecasts: GROUPYear Ending Dec 2025 RevenueY400.00 mln Operating Profit(Y670.00 mln) Pretax Profit(Y680.00 mln) Net Profit(Y680.00 mln) Per share Earnings(Y15.88) Figures in parentheses are losses. Results are based on Japanese accounting standards. \n\n  (END) Dow Jones Newswires\n\n\nD. Western Therapeutics Institute Inc. (4576.TO) Japan 1st Quarter Ended March 31 GROUP20252024 RevenueY96.00 mlnY104.00 mln Operating Profit(Y142.00 mln)(Y318.00 mln) Pretax Profit(Y149.00 mln)(Y320.00 mln) Net Profit(Y150.00 mln)(Y320.00 mln) Per share Earnings(Y3.41)(Y9.99) Figures in parentheses are losses. Results are based on Japanese accounting standards. \n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2025 02:42 ET (06:42 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}